Implications of Changes in U.S. Food and Drug Administration Prescribing Information Regarding the Safety and Use of Asthma Biologics during Pregnancy.

Subjects

Subjects :

Female
Humans
Pregnancy
United States
United States Food and Drug Administration
Anti-Asthmatic Agents pharmacology
Asthma drug therapy
Biological Products pharmacology
Drug Prescriptions standards
Pregnancy Complications drug therapy

Details

Language :

English

ISSN :

2325-6621

Volume :

15

Issue :

10

Database :

MEDLINE

Journal :

Annals of the American Thoracic Society

Publication Type :

Academic Journal

Accession number :

30130420

Full Text :

https://doi.org/10.1513/AnnalsATS.201806-400PP